| scholarly article | Q13442814 |
| P50 | author | Markus Büchler | Q89169 |
| Claudio Bassi | Q88448313 | ||
| P2093 | author name string | Hans G Beger | |
| Pauli A Puolakkainen | |||
| Karl Wegscheider | |||
| Andrew A Gumbs | |||
| Esko A Kemppainen | |||
| Bettina M Rau | |||
| P2860 | cites work | Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis | Q28345121 |
| APACHE II: a severity of disease classification system | Q29547729 | ||
| The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis | Q32125356 | ||
| Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. | Q33715609 | ||
| The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. | Q33872817 | ||
| Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis | Q33980630 | ||
| Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. | Q34301553 | ||
| 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. | Q35094247 | ||
| Natural history of necrotizing pancreatitis | Q35140147 | ||
| Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis | Q35358768 | ||
| Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis | Q35685202 | ||
| Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy | Q35855891 | ||
| Management of the critically ill patient with severe acute pancreatitis | Q35984102 | ||
| Laboratory markers of severe acute pancreatitis | Q36064587 | ||
| Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis | Q40826137 | ||
| A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. | Q40905013 | ||
| A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis | Q44048827 | ||
| Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study | Q44120216 | ||
| Severe acute pancreatitis: nonsurgical treatment of infected necroses | Q44414132 | ||
| Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial | Q44825204 | ||
| Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant | Q45042039 | ||
| The continuing challenge of early mortality in acute pancreatitis | Q45070038 | ||
| The clinical value of procalcitonin in early assessment of acute pancreatitis. | Q46572215 | ||
| Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System | Q47595427 | ||
| Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. | Q47880659 | ||
| Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis | Q47944679 | ||
| Acute necrotizing pancreatitis: treatment strategy according to the status of infection | Q50185728 | ||
| Calcitonin Precursors: Early Markers of Gut Barrier Dysfunction in Patients With Acute Pancreatitis | Q52859823 | ||
| Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis. | Q52939583 | ||
| Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. | Q55036468 | ||
| Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis | Q57010154 | ||
| Bacterial contamination of pancreatic necrosis. A prospective clinical study | Q68883830 | ||
| Early diagnosis of pancreatic infection by computed tomography-guided aspiration | Q69445425 | ||
| Management of sterile necrosis in instances of severe acute pancreatitis | Q71723553 | ||
| High serum procalcitonin concentrations in patients with sepsis and infection | Q72211281 | ||
| Procalcitonin strip test in the early detection of severe acute pancreatitis | Q73416917 | ||
| Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis | Q73436015 | ||
| Early measurement of procalcitonin does not predict severity in patients with acute pancreatitis | Q73876941 | ||
| Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study | Q73906897 | ||
| Early prediction of severity in acute pancreatitis. Is this possible? | Q74764513 | ||
| European survey of surgical strategies for the management of severe acute pancreatitis | Q79943875 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute pancreatitis | Q854573 |
| P304 | page(s) | 745-754 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. | |
| P478 | volume | 245 |
| Q37799431 | Acute Pancreatitis with an Emphasis on Infection |
| Q43088026 | Acute pancreatitis at the beginning of the 21st century: the state of the art. |
| Q89389659 | Acute pancreatitis following scoliosis surgery: description and clinical course in 14 adolescents |
| Q41518398 | Alterations of serum cytokine levels and their relation with inflammatory markers in candidemia. |
| Q51771520 | Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. |
| Q35622257 | Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? |
| Q53319046 | Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. |
| Q46010859 | Changes in blood polyamine levels in human acute pancreatitis. |
| Q64257369 | Combination of S100B and procalcitonin improves prognostic performance compared to either alone in patients with cardiac arrest: A prospective observational study |
| Q36955510 | Conservative approach in the management of severe acute pancreatitis: eight-year experience in a single institution |
| Q53833044 | Correlation of Procalcitonin and C-Reactive Protein with Intra-Abdominal Hypertension in Intra-Abdominal Infections: Their Predictive Role in the Progress of the Disease. |
| Q37852470 | Diagnostic and prognostic biomarkers of sepsis in critical care |
| Q37982806 | Differential roles of inflammatory cells in pancreatitis. |
| Q34225639 | Early nasogastric enteral nutrition for severe acute pancreatitis: a systematic review |
| Q38240877 | Early phase of acute pancreatitis: Assessment and management |
| Q38660305 | Early prediction of infected pancreatic necrosis secondary to necrotizing pancreatitis |
| Q42604070 | Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model |
| Q42003300 | From moderately severe to severe hypertriglyceridemia induced acute pancreatitis: circulating miRNAs play role as potential biomarkers |
| Q85068488 | Gut Barrier Dysfunction in Critically Ill Surgical Patients With Abdominal Compartment Syndrome |
| Q84605283 | Increased admission serum estradiol level is correlated with high mortality in patients with severe acute pancreatitis |
| Q41984696 | Infected pancreatic necrosis: not necessarily a late event in acute pancreatitis |
| Q55004912 | Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase. |
| Q92048334 | Initially elevated arterial lactate as an independent predictor of poor outcomes in severe acute pancreatitis |
| Q38479517 | Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. |
| Q38546852 | Laboratory markers predicting severity of acute pancreatitis. |
| Q92260742 | PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial |
| Q36785154 | Predicting severity of acute pancreatitis |
| Q38087919 | Predictors of adverse outcomes in acute pancreatitis: new horizons |
| Q36193386 | Predictors of critical acute pancreatitis: a prospective cohort study |
| Q37413459 | Prevention, detection, and management of infected necrosis in severe acute pancreatitis |
| Q37157970 | Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? |
| Q38736343 | Procalcitonin Strip Test as an Independent Predictor in Acute Pancreatitis |
| Q40243836 | Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery |
| Q43544967 | Procalcitonin as a prognostic biomarker of severe sepsis and septic shock |
| Q93016551 | Procalcitonin, C-Reactive Protein, and Neutrophil Ratio Contribute to the Diagnosis and Prognosis of Severe Acute Pancreatitis |
| Q38197674 | Prognostic markers in acute pancreatitis. |
| Q41704125 | Prognostic value of admission red blood cell distribution width in acute pancreatitis: a systematic review. |
| Q90329380 | Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitis |
| Q38043183 | Role of early systemic inflammatory response in simultaneous pancreas-kidney transplantation. |
| Q87861297 | Role of heart rate variability in predicting the severity of severe acute pancreatitis |
| Q48234547 | Role of inflammatory markers as predictors of laparotomy in patients presenting with acute abdomen. |
| Q38107378 | Scoring of human acute pancreatitis: state of the art. |
| Q38826374 | Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis. |
| Q37984502 | Serum procalcitonin in the diagnosis and management of intra-abdominal infections |
| Q33622686 | Serum profiles of C-reactive protein, interleukin-8, and tumor necrosis factor-alpha in patients with acute pancreatitis |
| Q42550331 | Severe acute pancreatitis: Clinical course and management |
| Q37060412 | Severe acute pancreatitis: pathogenetic aspects and prognostic factors |
| Q37172829 | Soluble E-cadherin: an early marker of severity in acute pancreatitis. |
| Q48471585 | The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis |
| Q38225139 | Update on procalcitonin measurements |
| Q84325877 | [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients] |
Search more.